Panel Discussion | Who Should Get an Embolic Protection Device During TAVR?

Monday, March 9, 2026

2:10 PM - 2:33 PM EST

Location: Lincoln

Moderator(s)

Michael G. Dwyer, PhD

Associate Professor of Neurology and Biomedical Informatics
University at Buffalo
Buffalo, New York, United States

Disclosure(s): Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
Samir R. Kapadia, MD, FSCAI

Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Neel Butala, MD

Medical Director of Structural Heart Disease and Intervention
Rocky Mountain Regional VA Medical Center

Disclosure(s): Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Catch Bio: Consulting Fees (e.g., advisory boards) (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing); Emboline, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); HiLabs: Consulting Fees (e.g., advisory boards) (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing)
Abhishek Chaturvedi, MD

Interventional Cardiologist & Assistant Professor of Medicine
West Virginia University Heart & Vascular Institute, United States

Disclosure(s): No financial relationships to disclose
David J. Cohen, MD, FSCAI

Director of Clinical and Outcomes Research
Cardiovascular Research Foundation
New York, New York, United States

Disclosure(s): Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Disclosure(s):

Michael G. Dwyer, PhD: Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Samir R. Kapadia, MD, FSCAI: No financial relationships to disclose

Neel Butala, MD: Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Catch Bio: Consulting Fees (e.g., advisory boards) (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing); Emboline, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); HiLabs: Consulting Fees (e.g., advisory boards) (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing)

Abhishek Chaturvedi, MD: No financial relationships to disclose

David J. Cohen, MD, FSCAI: Zoll Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)